Nature Medicine, Published online: 28 February 2025; doi:10.1038/s41591-024-03435-3
MethyLYZR, an epigenetic classifier of brain tumors, provides clinically relevant cancer classification results within 15 min of sequencing, with potential applications for neurosurgical intraoperative use.
